These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3976647)

  • 21. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
    Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
    J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion.
    Lee EJ; Norris D; Schiffer CA
    Transfusion; 1987; 27(3):245-7. PubMed ID: 3590287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
    Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates.
    Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA
    Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncology Grand Rounds. Platelet transfusion--clinical applications in the oncology setting.
    Daly PA
    Am J Med Sci; 1980; 280(3):130-42. PubMed ID: 7457494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis on the effectiveness in 727 times of platelet transfusion].
    Gui R; Nie XM; Wen XH; Liu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):381-5. PubMed ID: 22541103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
    Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
    Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial.
    Klumpp TR; Herman JH; Gaughan JP; Russo RR; Christman RA; Goldberg SL; Ackerman SJ; Bleecker GC; Mangan KF
    Transfusion; 1999 Jul; 39(7):674-81. PubMed ID: 10413273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of anti-D to improve post-transfusion platelet response: a randomized trial.
    Heddle NM; Klama L; Kelton JG; Meyer R; Walker I; Dickson L; Chambers S; Levine MN
    Br J Haematol; 1995 Jan; 89(1):163-8. PubMed ID: 7833257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Massive platelet transfusion after splenectomy in a case of myelofibrosis.
    Toolis F; Paton L
    Scand J Haematol; 1979 Oct; 23(4):317-22. PubMed ID: 538414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal Platelet Transfusions and Future Areas of Research.
    Sola-Visner M; Bercovitz RS
    Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous platelet transfusion in alloimmunized patients with acute leukemia.
    Funke I; Wiesneth M; Koerner K; Cardoso M; Seifried E; Kubanek B; Heimpel H
    Ann Hematol; 1995 Oct; 71(4):169-73. PubMed ID: 7578522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloimmunization following prophylactic granulocyte transfusion.
    Schiffer CA; Aisner J; Daly PA; Schimpff SC; Wiernik PH
    Blood; 1979 Oct; 54(4):766-74. PubMed ID: 476300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
    Levin MD; de Veld JC; van der Holt B; van 't Veer MB
    Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the management of acute nonlymphocytic leukemia.
    Wiernik PH
    Arch Intern Med; 1976 Dec; 136(12):1399-403. PubMed ID: 826228
    [No Abstract]   [Full Text] [Related]  

  • 38. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.